Sai Life Sciences Limited has officially released the transcript from its recent earnings conference call. The session, held on May 15, 2026, focused on the company’s audited financial results for both the final quarter and the full fiscal year ending March 31, 2026. Investors and stakeholders can now access the detailed discussion regarding the company’s operational performance and strategic growth trajectory through the official company website.
Earnings Call Overview
Following the successful conclusion of the fiscal year, Sai Life Sciences hosted an earnings call on Friday, 15 May 2026, at 04:00 PM (IST). The management team utilized this forum to provide clarity on the audited financial outcomes for the quarter and year ended 31 March 2026. This discussion is essential for stakeholders looking to understand the company’s fiscal health and market positioning as it concludes its latest financial cycle.
Accessing the Transcript
The company has made the full transcript of the proceedings available to the public. By publishing these records, Sai Life Sciences continues its commitment to transparency and communication with the investment community. The document covers the key financial highlights and management insights shared during the interactive Q&A session with analysts and market participants.
Fiscal Highlights
The earnings call addressed the company’s performance for the quarter (Jan-Mar 2026) and the overall progress made throughout the 2025-26 fiscal year. Interested parties are encouraged to visit the official company website to review the detailed transcript, which provides context to the audited financial results previously disclosed to the exchanges.
Source: BSE
